Dr. Corless is Professor of Pathology at Oregon Health & Science University and serves as the executive director of the Knight Diagnostic Laboratories. His specialty is clinical implementation of new testing technologies for the molecular characterization of solid tumors.
Measuring Breast Cancer Biomarkers With The Nanostring GeoMx DSP
The Nanostring GeoMx Digital Spatial Profiler can generate tumor-specific quantitative readouts for over 90 protein and phospho-protein biomarkers using a multiplexed antibody approach. We developed a panel for measuring clinically informative biomarkers in samples of FFPE breast cancer and demonstrated its robust performance across multiple laboratories. The panel is ideal for analyzing clinical trial samples.
Ira Mellman, Genentech
Human cells have been successfully used as treatment for blood cancers for decades but translating the promise to cell-based treatment for solid tumors has been slow. The advent of gene-editing techniques such as CRISPR, coupled with advances in our understanding of immunology and optimization of growing, manufacturing, transporting, storing, and handling specialized biological samples and materials is transforming the cell therapy field. We will hear in this session about some of the most promising work in the field, as well as the challenges in overcoming resistance